Top Markets
Coin of the day
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Rang in Aktien #30341
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Aktienkurs
$0.13400411
Marktkapitalisierung
$17.21M
Veränderung (1 Tag)
-7.32%
Veränderung (1 Jahr)
-70.34%
Land
AU
Handel Argenica Therapeutics Ltd (AGN)

Kategorie

Kursverlauf für Argenica Therapeutics Ltd (AGN)
Höchster Schlusskurs: $0.13 am 2026-08-01

Niedrigster Schlusskurs: $0.15 am 2021-06-01
Kursverlauf der Aktie von Argenica Therapeutics Ltd von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.80%
2025 -57.63%
2024 25.20%
2023 0.96%
2022 -36.24%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$115.26 -20.82%
AU
$735.86 6.07%
CH
$1.06K -5.95%
KR